Bull
$791.95
Scenario price
$397.560
-0.636 (-0.16%)At close
Roper Technologies, Inc. is a diversified technology company. It operates businesses that design and develop vertical software and technology-enabled products for a variety of defensible niche markets. The Company operates through three segments: Application Software, Network Software and Technology Enabled Products. The Application Software segment includes Aderant, Clinisys, Data Innovations, Deltek, Frontline, IntelliTrans, PowerPlan, Procare, Strata, Transact/CBORD, and Vertafore. The Network Software segment includes ConstructConnect, DAT, Foundry, iPipeline, iTradeNetwork, Loadlink, MHA, SHP, and SoftWriters. The Technology Enabled Products segment includes CIVCO Medical Solutions, FMI, Inovonics, IPA, Neptune, Northern Digital, rf IDEAS, and Verathon. Aderant is a comprehensive management software solution for law and other professional services firms. Data Innovations is a software solution that enables the enterprise management of hospitals and independent laboratories.
Roper Technologies Inc is a good buy right now due to its current price of $382.71 being below the average analyst price target of $450, suggesting significant upside potential. Additionally, the company has shown a remarkable gross margin of 69.71% in the latest quarter and a strong earnings surprise of 1.70% in the last report, indicating robust financial health. However, a key risk is the high RSI of 79.825, which suggests the stock may be overbought in the short term.
Argus
$450
2026-08-06
Argus
2026-08-06
Price Target
$450
RBC Capital
$417
2026-07-24
RBC Capital
2026-07-24
Price Target
$417
Piper Sandler
$526
2026-07-24
Piper Sandler
2026-07-24
Price Target
$526
Baird
$480
2026-07-24
Baird
2026-07-24
Price Target
$480
Raymond James
—
2026-07-22
Raymond James
2026-07-22
Price Target
—
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Universities Expand Partnership with HID to Enhance Mobile Credential Adoption

Strong Outlook for Q3 Earnings Season Amid Market Caution

iPipeline Named Finalist for 2026 AI Innovation Award

Frontline Education Showcases New Initiative at AASPA Annual Conference

U.S. Contract Freight Rates Rise While Spot Rates Decline
Roper Technologies, Inc. is a diversified technology company. It operates businesses that design and develop vertical software and technology-enabled products for a variety of defensible niche markets. The Company operates through three segments: Application Software, Network Software and Technology Enabled Products. The Application Software segment includes Aderant, Clinisys, Data Innovations, Deltek, Frontline, IntelliTrans, PowerPlan, Procare, Strata, Transact/CBORD, and Vertafore. The Network Software segment includes ConstructConnect, DAT, Foundry, iPipeline, iTradeNetwork, Loadlink, MHA, SHP, and SoftWriters. The Technology Enabled Products segment includes CIVCO Medical Solutions, FMI, Inovonics, IPA, Neptune, Northern Digital, rf IDEAS, and Verathon. Aderant is a comprehensive management software solution for law and other professional services firms. Data Innovations is a software solution that enables the enterprise management of hospitals and independent laboratories. It operates in the Technology sector (INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, A industry).
Roper Technologies Inc is a good buy right now due to its current price of $382.71 being below the average analyst price target of $450, suggesting significant upside potential. Additionally, the company has shown a remarkable gross margin of 69.71% in the latest quarter and a strong earnings surprise of 1.70% in the last report, indicating robust financial health. However, a key risk is the high RSI of 79.825, which suggests the stock may be overbought in the short term.
13 analysts cover ROP: 10 rate it Buy, 3 Hold and 0 Sell. The average price target is 558.36.
No posts yet
Sign up or log in to join the discussionThis page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.